Pneumococcus Resources
Policy and Decision making
- Position papers on pneumococcal vaccines
-
Global Burden of Disease - Pneumococcus (Lancet, 2011)
pdf, 552kb -
WHO Data Underscores Global Threat of the World’s Leading Child Killer (Sep 2011)
pdf, 463kb - » » WHO Initiative for Vaccine Research (IVR) page on Streptococcus pneumoniae
- » » PneumoADIP
- » » Centers for Disease Control and Prevention (CDC) page on Pneumonia
Vaccine characteristics and safety
- Global Advisory Committee on Vaccine Safety (GACVS) statement on PCV
- Update on two-dose presentation of preservative-free 10-valent pneumococcal conjugate vaccine from GlaxoSmithKline (GSK) (Synflorix™) (2012)
- Prequalification of one- and two-dose presentations of preservative-free 10-valent pneumococcal conjugate vaccine from Glaxo SmithKline (GSK) (Synflorix TM) (2010)
Costing and financing
Implementation
Health worker training materials
Integrated approaches
- Integrated approaches to prevent and manage pneumonia and diarrhoea for achievement of MDG 4 Report of South-East Asia regional workshop (2011)
- Global action plan for prevention and control of pneumonia (GAPP) (2009)
- Global action plan for the prevention and control of pneumonia (GAPP): Report of an informal consultation (2008)
Monitoring and Surveillance
Last updated: October 2012